300888.SZ
稳健医疗
SZSE · Healthcare · C 制造业 · CN
CNY 28.49
−1.83%Year over year
Reported trailing growth
- Revenue
- +13.9%
- EBITDA
- —
- EBIT
- +5.0%
- EPS
- +1.1%
- Free cash flow
- +120.8%
- Operating cash flow
- +47.1%
Forward estimates
Based on analyst estimates
- Revenue
- -74.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.2%
- EBITDA
- -12.9%
- EBIT
- -18.6%
- Net income
- -22.5%
- EPS
- -22.1%
- Free cash flow
- -17.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026